找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Checkpoint Responses in Cancer Therapy; Wei Dai Book 2008 Humana Press 2008 DNA.apoptosis.biotechnology.cancer.cancer research.cancer ther

[復(fù)制鏈接]
樓主: Constrict
11#
發(fā)表于 2025-3-23 11:53:01 | 只看該作者
12#
發(fā)表于 2025-3-23 14:58:02 | 只看該作者
13#
發(fā)表于 2025-3-23 22:02:37 | 只看該作者
14#
發(fā)表于 2025-3-23 22:46:11 | 只看該作者
Cancer Drug Discovery and Developmenthttp://image.papertrans.cn/c/image/224213.jpg
15#
發(fā)表于 2025-3-24 05:28:32 | 只看該作者
https://doi.org/10.1007/978-1-4302-1834-0 end, RB function is commonly abrogated in tumorigenesis, thereby contributing to the uncontrolled proliferation of cancer cells. However, it is becoming increasingly clear that RB is not only involved in the etiology and progression of cancer, but also modifies the response to specific therapeutic
16#
發(fā)表于 2025-3-24 08:11:38 | 只看該作者
https://doi.org/10.1007/978-1-4302-1834-0structure of DNA in the cell, regulate under- and overwinding of the double helix, and remove knots and tangles from the genetic material. In order to perform their critical cellular functions, topoisomerases generate DNA strand breaks as requisite intermediates in their catalytic cycles. Consequent
17#
發(fā)表于 2025-3-24 12:26:53 | 只看該作者
https://doi.org/10.1007/978-1-4302-1834-0sm of the G2 checkpoint s cascade. In addition, screening procedures to identify candidate compounds, currently available compounds, and compounds in clinical trials with G2 checkpoint-abrogating potential are discussed.
18#
發(fā)表于 2025-3-24 14:58:12 | 只看該作者
19#
發(fā)表于 2025-3-24 19:27:08 | 只看該作者
20#
發(fā)表于 2025-3-25 01:30:48 | 只看該作者
Advanced and Alternate MapReduce Techniques,indle checkpoint is a cell-cycle surveillance mechanism that prevents premature sister-chromatid separation and ensures the fidelity of chromosome segregation. A defective spindle checkpoint results in aneuploidy and contributes to tumorigenesis. On the other hand, many tumor cells still exhibit a p
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 13:00
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
都江堰市| 东乡族自治县| 中方县| 吉水县| 锦屏县| 鸡东县| 海林市| 萝北县| 沙湾县| 隆子县| 治县。| 崇左市| 南阳市| 金沙县| 武鸣县| 岱山县| 通道| 九江县| 塘沽区| 桓仁| 天峻县| 克山县| 北流市| 称多县| 冀州市| 上高县| 高密市| 湖口县| 诸暨市| 耒阳市| 峨眉山市| 郎溪县| 垦利县| 玉屏| 东海县| 屏南县| 安阳市| 云安县| 那坡县| 安福县| 海伦市|